| Issue |
E3S Web Conf.
Volume 308, 2021
2021 6th International Conference on Materials Science, Energy Technology and Environmental Engineering (MSETEE 2021)
|
|
|---|---|---|
| Article Number | 02014 | |
| Number of page(s) | 6 | |
| Section | Environmental Ecology and Biochemical Testing | |
| DOI | https://doi.org/10.1051/e3sconf/202130802014 | |
| Published online | 27 September 2021 | |
Research on the development of cancer drugs for children
New York University, 70 Washington Square South New York, NY, 10012
* Corresponding author: yw5501@nyu.edu
The development of pediatric cancer drugs is inefficient and must requires a significant development to improve the current situation. According to the research on the development of pediatric cancer drugs, the market condition is analyzed and compared with adult cancer drugs. It is found that even though the drug market for pediatric cancer is significantly smaller than adult cancer’s drug market, it is still important that pediatric cancer drugs are developed in order to better serve the treatment for childhood cancer, and increase the survival rate for malign cancer cases. Through thorough research it also appeared that while the government provides some beneficial programs and insurances for children experiencing pediatric cancer, better insurance plans should be identified. Another important finding throughout research results in the government and legislation area, where the pediatric cancer drugs development process is analysed and has found some potential for the future. As a whole, the effort of the government in both the drug development period and the legislation area with the combination of big pharmaceutical companies’ efforts and the potential creation of new kinds of insurances, the situation for pediatric cancer drugs development can experience a positive change.
© The Authors, published by EDP Sciences, 2021
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.